Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells
Citations Over TimeTop 10% of 2013 papers
Abstract
Salinomycin is perhaps the first promising compound that was discovered through high throughput screening in cancer stem cells. This novel agent can selectively eliminate breast and other cancer stem cells, though the mechanism of action remains unclear. In this study, we found that salinomycin induced autophagy in human non-small cell lung cancer (NSCLC) cells. Furthermore, we demonstrated that salinomycin stimulated endoplasmic reticulum stress and mediated autophagy via the ATF4-DDIT3/CHOP-TRIB3-AKT1-MTOR axis. Moreover, we found that the autophagy induced by salinomycin played a prosurvival role in human NSCLC cells and attenuated the apoptotic cascade. We also showed that salinomycin triggered more apoptosis and less autophagy in A549 cells in which CDH1 expression was inhibited, suggesting that the inhibition of autophagy might represent a promising strategy to target cancer stem cells. In conclusion, these findings provide evidence that combination treatment with salinomycin and pharmacological autophagy inhibitors will be an effective therapeutic strategy for eliminating cancer cells as well as cancer stem cells.
Related Papers
- → Salinomycin Toxicity in Turkeys(1986)50 cited
- → Effect of Ionophorous Anticoccidials on Invasion and Development of Eimeria: Comparison of Sensitive and Resistant Isolates and Correlation with Drug Uptake(1987)49 cited
- → Effects on health, performance, and tissue residues of the ionophore antibiotic salinomycin in finishing broilers (21 to 38 d)(2018)9 cited
- → Synthetic Study of Salinomycin (Synthesis of C18-C29 Fragment)(1986)
- → Anticancer mechanism of salinomycin(2014)